Cardamonin inhibits the expression of P-glycoprotein and enhances the anti-proliferation of paclitaxel on SKOV3-Taxol cells
Author:
Funder
Natural Science Foundation of Fujian Province
Publisher
Springer Science and Business Media LLC
Subject
Molecular Medicine
Link
https://link.springer.com/content/pdf/10.1007/s11418-021-01583-1.pdf
Reference54 articles.
1. Reid F, Bhatla N, Oza AM, Blank SV, Cohen R, Adams T et al (2021) The World Ovarian Cancer Coalition Every Woman Study: identifying challenges and opportunities to improve survival and quality of life. Int J Gynecol Cancer 31:238–244
2. Tate S, Nishikimi K, Matsuoka A, Otsuka S, Shozu M (2021) Safety and efficacy of weekly paclitaxel and cisplatin chemotherapy for ovarian cancer patients with hypersensitivity to carboplatin. Cancers 13:640–651
3. Wu J, Wang Q, Dong X, Xu M, Yang J, Yi X et al (2021) Biocompatible AIEgen/p-glycoprotein siRNA@reduction-sensitive paclitaxel polymeric prodrug nanoparticles for overcoming chemotherapy resistance in ovarian cancer. Theranostics 11:3710–3724
4. Lau MT, Ghazanfar S, Parkin A, Chou A, Rouaen JR, Littleboy JB et al (2020) Systematic functional identification of cancer multi-drug resistance genes. Genome Biol 21:27
5. Zhou SF (2008) Structure, function and regulation of P-glycoprotein and its clinical relevance in drug disposition. Xenobiotica 38:802–832
Cited by 7 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Molecular Evidence of the Bio-activities of Traditional Home Medicine Ingredients;Current Topics in Medicinal Chemistry;2024-07-02
2. Cardamomin Inhibits the Proliferation and Tumorigenesis of Bladder Cancer by ESR1 in PI3K/AKT Pathway;Biochemical Genetics;2024-06-12
3. Site-specific delivery of cisplatin and paclitaxel mediated by liposomes: A promising approach in cancer chemotherapy;Environmental Research;2023-12
4. Strategies to overcome cancer multidrug resistance (MDR) through targeting P-glycoprotein (ABCB1): An updated review;Pharmacology & Therapeutics;2023-09
5. Paclitaxel and docetaxel resistance in prostate cancer: Molecular mechanisms and possible therapeutic strategies;Biomedicine & Pharmacotherapy;2023-04
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3